Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in 2015

European Healthtech startup funding raised during 2015.

In 2015, 211 European Healthtech companies closed 228 funding rounds and raised €1.8B in equity funding (excluding debt and grants). Debt rounds added €103M. Switzerland led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 18 Nov 2026.

Equity funding
€1.8B
excl. debt & grants · +€103M debt
Funding rounds
228
Companies
211
Top country
Switzerland

Healthtech: last three years

change vs the year before
YearEquityChangeRoundsChangeDebt
2013€631M+31.5%121+63.5%€914k
2014€928M+47.1%134+10.7%€649k
2015€1.8B+89.5%228+70.1%€103M
Break down 2015 by period
Rank among sectors
#4
8.8% of sector funding
Debt financing
€103M
5.5% of total
Top-10 round share
36.4%
of disclosed capital

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, 2015 — interactive chart.
Data table
FundingRounds
Jan€102M16
Feb€873k6
Mar€79M15
Apr€171M19
May€81M14
Jun€56M17
Jul€119M21
Aug€207M11
Sep€405M29
Oct€184M26
Nov€378M31
Dec€102M23

Top countries

by € raised
Healthtech — top countries by capital, 2015 — interactive chart.
Data table
Healthtech — top countries by capital, 2015
Switzerland€395M
UK€362M
Israel€206M
France€188M
Germany€182M
Netherlands€115M
Denmark€92M
Sweden€85M

Stage mix

by € raised
Healthtech — stage mix, 2015 — interactive chart.
Data table
Healthtech — stage mix, 2015
Series B€375M
Series C€367M
Series A€326M
Growth/Late€296M
Series D+€209M
Debt€103M
Early VC€91M
Seed€76M
Grant€24M
Other€19M

Exits & M&A

13 Acquisition · 2 Buyout

15 exits · €821M disclosed.

Biotie TherapiesAcquisitionSep 2015€330M
Dezima PharmaAcquisitionMar 2015€273M
WiThingsAcquisitionDec 2015€170M
ClipFortAcquisitionDec 2015€26M
AMO PharmaBuyoutJun 2015€23M

Largest equity rounds

by disclosed amount, 2015
CompanyStageDateAmount
CureVacSeries D+Nov 2015€100M
CeQurSeries CSep 2015€89M
BenevolentGrowth/LateAug 2015€80M
MerusSeries CAug 2015€73M
ADC TherapeuticsGrowth/LateSep 2015€71M
CRISPR TherapeuticsSeries BApr 2015€59M
ObsEvaSeries BNov 2015€54M
CureVacSeries D+Mar 2015€46M
KymabSeries BMay 2015€45M
SanifitSeries CSep 2015€37M

Largest debt rounds

debt financing, 2015; not in the equity total
CompanyStageDateAmount
SymphogenDebtOct 2015€68M
DNAe LTDDebtNov 2015€35M
Silk BiomaterialsDebtDec 2015€500k
Mint LabsDebtFeb 2015€260k

Top investors

most active in 2015, by deal count

Source: Tech.eu Funding Explorer · data as of 18 Nov 2026 · licence CC BY 4.0 · Methodology